Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 3 Hazard ratios for the combined associations of hs-CRP and cognitive impairment with all-cause mortality (N = 1447)

From: Combined associations of hs-CRP and cognitive function with all-cause mortality among oldest-old adults in Chinese longevity areas: a prospective cohort study

Groups/HR

No. of deaths

Model 1

Model 2a

1: hs-CRP ≤ 3.0 mg/L and normal cognition

312

1

1

2: hs-CRP > 3.0 mg/L and normal cognition

117

1.80 (1.24, 2.61)

1.70 (1.13, 2.56)

3: hs-CRP ≤ 3.0 mg/L and CI

286

2.79 (1.82, 4.28)

2.39 (1.61, 3.55)

4: hs-CRP > 3.0 mg/L and CI

111

4.61 (3.16, 6.72)

3.56 (2.35, 5.38)

P for trend

–

< 0.001

< 0.001

  1. Model 1 adjusted for age and sex; model 2 further adjusted for drinking, smoking, marital status, regular exercise, medication, BMI, central obesity, self-reported history of hypertension, diabetes mellitus, heart disease, stroke and cerebrovascular disease, respiratory disease and cancer. CI = cognitive impairment
  2. a P for interaction< 0.01
Back to article page

Immunity & Ageing

ISSN: 1742-4933

Contact us